Exelon Non Current Liabilities Total vs Net Receivables Analysis

EXC Stock

USD 38.33 0.51 1.35%

Exelon financial indicator trend analysis is much more than just examining Exelon latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Exelon is a good investment. Please check the relationship between Exelon Non Current Liabilities Total and its Net Receivables accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Exelon. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.

For information on how to trade Exelon Stock refer to our How to Trade Exelon Stock guide.

Non Current Liabilities Total vs Net Receivables

Non Current Liabilities Total vs Net Receivables Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Exelon Non Current Liabilities Total account and Net Receivables. At this time, the significance of the direction appears to have strong relationship.

The correlation between Exelon's Non Current Liabilities Total and Net Receivables is 0.71. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Net Receivables in the same time period over historical financial statements of Exelon, assuming nothing else is changed. The correlation between historical values of Exelon's Non Current Liabilities Total and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Exelon are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Non Current Liabilities Total i.e., Exelon's Non Current Liabilities Total and Net Receivables go up and down completely randomly.

Correlation Coefficient

0.71

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Non Current Liabilities Total

Net Receivables

Most indicators from Exelon's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Exelon current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Exelon. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.

For information on how to trade Exelon Stock refer to our How to Trade Exelon Stock guide.At present, Exelon's Issuance Of Capital Stock is projected to increase significantly based on the last few years of reporting.

	2021	2022	2023	2024 (projected)
Gross Profit	7.0B	8.0B	8.9B	7.7B
Total Revenue	17.9B	19.1B	21.7B	16.5B

Gross Profit Total Revenue

Exelon fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Other Liab	Other Assets	Long Term Debt
Common Stock Shares Outstanding		0.93	0.72	0.64	0.87	0.93	0.93	0.69	0.62	0.91	0.13	0.92	0.07	0.13	0.73	0.93	0.58	0.84	0.08	0.92	0.78	0.73	0.98	0.77	0.46	0.79
Total Assets	0.93		0.72	0.81	0.97	0.99	0.95	0.69	0.8	0.87	0.05	1.0	0.16	0.05	0.72	1.0	0.63	0.86	0.22	1.0	0.84	0.74	0.9	0.94	0.61	0.82
Short Long Term Debt Total	0.72	0.72		0.47	0.7	0.67	0.78	0.99	0.32	0.68	-0.18	0.74	0.05	-0.18	0.43	0.71	0.35	0.78	0.51	0.73	0.43	0.74	0.71	0.69	0.43	0.85
Other Current Liab	0.64	0.81	0.47		0.87	0.8	0.6	0.45	0.74	0.49	0.05	0.79	0.55	0.04	0.38	0.79	0.28	0.5	0.16	0.81	0.76	0.44	0.65	0.82	0.64	0.61
Total Current Liabilities	0.87	0.97	0.7	0.87		0.94	0.88	0.68	0.77	0.78	-0.03	0.97	0.3	-0.03	0.63	0.96	0.52	0.76	0.22	0.97	0.79	0.79	0.85	0.92	0.65	0.79
Total Stockholder Equity	0.93	0.99	0.67	0.8	0.94		0.93	0.64	0.81	0.85	0.11	0.98	0.18	0.11	0.71	0.98	0.62	0.84	0.22	0.98	0.85	0.71	0.91	0.91	0.57	0.78
Property Plant And Equipment Net	0.93	0.95	0.78	0.6	0.88	0.93		0.76	0.64	0.93	0.0	0.96	-0.07	0.0	0.73	0.96	0.66	0.95	0.29	0.95	0.71	0.81	0.91	0.87	0.52	0.88
Net Debt	0.69	0.69	0.99	0.45	0.68	0.64	0.76		0.28	0.64	-0.3	0.72	0.08	-0.3	0.4	0.68	0.29	0.77	0.56	0.71	0.35	0.75	0.66	0.66	0.41	0.85
Retained Earnings	0.62	0.8	0.32	0.74	0.77	0.81	0.64	0.28		0.61	0.2	0.78	0.19	0.2	0.68	0.79	0.7	0.55	-0.04	0.79	0.84	0.41	0.55	0.83	0.5	0.36
Accounts Payable	0.91	0.87	0.68	0.49	0.78	0.85	0.93	0.64	0.61		0.14	0.86	-0.27	0.14	0.89	0.87	0.8	0.88	0.07	0.86	0.77	0.68	0.89	0.75	0.45	0.71
Cash	0.13	0.05	-0.18	0.05	-0.03	0.11	0.0	-0.3	0.2	0.14		-0.01	-0.2	1.0	0.19	0.04	0.34	-0.09	-0.51	0.02	0.5	-0.23	0.17	0.08	0.06	-0.19
Non Current Assets Total	0.92	1.0	0.74	0.79	0.97	0.98	0.96	0.72	0.78	0.86	-0.01		0.17	-0.01	0.69	1.0	0.6	0.88	0.27	1.0	0.8	0.77	0.89	0.94	0.6	0.85
Non Currrent Assets Other	0.07	0.16	0.05	0.55	0.3	0.18	-0.07	0.08	0.19	-0.27	-0.2	0.17		-0.2	-0.36	0.15	-0.52	-0.19	0.18	0.17	0.05	0.04	0.07	0.15	0.19	0.14
Cash And Short Term Investments	0.13	0.05	-0.18	0.04	-0.03	0.11	0.0	-0.3	0.2	0.14	1.0	-0.01	-0.2		0.19	0.04	0.34	-0.09	-0.51	0.02	0.5	-0.23	0.17	0.08	0.06	-0.19
Net Receivables	0.73	0.72	0.43	0.38	0.63	0.71	0.73	0.4	0.68	0.89	0.19	0.69	-0.36	0.19		0.71	0.89	0.67	-0.19	0.7	0.76	0.48	0.69	0.62	0.46	0.38
Non Current Liabilities Total	0.93	1.0	0.71	0.79	0.96	0.98	0.96	0.68	0.79	0.87	0.04	1.0	0.15	0.04	0.71		0.63	0.87	0.21	1.0	0.83	0.74	0.9	0.94	0.59	0.83
Inventory	0.58	0.63	0.35	0.28	0.52	0.62	0.66	0.29	0.7	0.8	0.34	0.6	-0.52	0.34	0.89	0.63		0.65	-0.2	0.62	0.75	0.4	0.52	0.64	0.35	0.29
Other Current Assets	0.84	0.86	0.78	0.5	0.76	0.84	0.95	0.77	0.55	0.88	-0.09	0.88	-0.19	-0.09	0.67	0.87	0.65		0.35	0.86	0.61	0.74	0.82	0.79	0.32	0.85
Other Stockholder Equity	0.08	0.22	0.51	0.16	0.22	0.22	0.29	0.56	-0.04	0.07	-0.51	0.27	0.18	-0.51	-0.19	0.21	-0.2	0.35		0.22	-0.19	0.39	0.09	0.3	0.22	0.58
Total Liab	0.92	1.0	0.73	0.81	0.97	0.98	0.95	0.71	0.79	0.86	0.02	1.0	0.17	0.02	0.7	1.0	0.62	0.86	0.22		0.82	0.75	0.9	0.94	0.61	0.83
Total Current Assets	0.78	0.84	0.43	0.76	0.79	0.85	0.71	0.35	0.84	0.77	0.5	0.8	0.05	0.5	0.76	0.83	0.75	0.61	-0.19	0.82		0.4	0.77	0.8	0.54	0.46
Short Term Debt	0.73	0.74	0.74	0.44	0.79	0.71	0.81	0.75	0.41	0.68	-0.23	0.77	0.04	-0.23	0.48	0.74	0.4	0.74	0.39	0.75	0.4		0.71	0.68	0.45	0.77
Common Stock	0.98	0.9	0.71	0.65	0.85	0.91	0.91	0.66	0.55	0.89	0.17	0.89	0.07	0.17	0.69	0.9	0.52	0.82	0.09	0.9	0.77	0.71		0.74	0.46	0.8
Other Liab	0.77	0.94	0.69	0.82	0.92	0.91	0.87	0.66	0.83	0.75	0.08	0.94	0.15	0.08	0.62	0.94	0.64	0.79	0.3	0.94	0.8	0.68	0.74		0.69	0.77
Other Assets	0.46	0.61	0.43	0.64	0.65	0.57	0.52	0.41	0.5	0.45	0.06	0.6	0.19	0.06	0.46	0.59	0.35	0.32	0.22	0.61	0.54	0.45	0.46	0.69		0.52
Long Term Debt	0.79	0.82	0.85	0.61	0.79	0.78	0.88	0.85	0.36	0.71	-0.19	0.85	0.14	-0.19	0.38	0.83	0.29	0.85	0.58	0.83	0.46	0.77	0.8	0.77	0.52

Click cells to compare fundamentals

Exelon Account Relationship Matchups

Exelon fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	974M	977M	980M	987M	997M	710.4M
Total Assets	125.0B	129.3B	133.0B	95.3B	101.5B	69.2B
Short Long Term Debt Total	37.8B	39.3B	34.5B	40.1B	44.0B	46.2B
Other Current Liab	4.4B	5.3B	10.2B	2.8B	2.8B	2.9B
Total Current Liabilities	14.2B	12.8B	16.1B	10.6B	9.6B	7.4B
Total Stockholder Equity	32.2B	32.6B	34.4B	24.7B	25.8B	17.4B
Property Plant And Equipment Net	80.2B	82.6B	64.6B	69.1B	73.6B	40.8B
Net Debt	37.2B	38.7B	33.9B	39.6B	43.6B	45.7B
Retained Earnings	16.3B	16.7B	16.9B	4.6B	5.5B	7.3B
Accounts Payable	3.6B	3.6B	2.4B	3.4B	2.8B	2.1B
Cash	587M	663M	672M	407M	445M	422.8M
Non Current Assets Total	112.9B	116.8B	119.1B	88.0B	93.8B	61.9B
Non Currrent Assets Other	3.2B	3.0B	39.4B	7.1B	8.0B	8.5B
Cash And Short Term Investments	587M	663M	672M	407M	445M	422.8M
Net Receivables	6.2B	4.7B	2.9B	3.6B	3.4B	3.2B
Liabilities And Stockholders Equity	125.0B	129.3B	133.0B	95.3B	101.5B	69.2B
Non Current Liabilities Total	76.2B	81.7B	82.1B	60.0B	66.2B	40.5B
Inventory	1.8B	1.7B	581M	755M	801M	914.0M
Other Current Assets	2.4B	3.5B	1.7B	2.0B	2.7B	1.4B
Total Liab	90.4B	94.4B	98.2B	70.6B	75.8B	51.3B
Total Current Assets	12.0B	12.6B	14.0B	7.3B	7.8B	7.4B
Short Term Debt	6.1B	3.9B	3.4B	4.4B	3.9B	2.2B
Common Stock	19.3B	19.4B	20.3B	20.9B	21.1B	12.1B
Accumulated Other Comprehensive Income	(3.2B)	(3.4B)	(2.8B)	(638M)	(726M)	(762.3M)
Other Liab	43.2B	46.2B	46.4B	24.1B	27.7B	24.2B
Other Assets	27.3B	3.3B	27.7B	12.0B	13.8B	13.3B
Long Term Debt	31.3B	35.1B	35.3B	35.7B	40.1B	23.1B
Common Stock Total Equity	19.3B	19.4B	20.3B	20.9B	24.0B	13.7B
Property Plant And Equipment Gross	80.2B	82.6B	114.5B	85.0B	90.8B	52.6B
Property Plant Equipment	80.2B	82.6B	84.2B	69.1B	79.4B	48.2B
Noncontrolling Interest In Consolidated Entity	2.3B	2.3B	2.3B	402M	462.3M	439.2M
Retained Earnings Total Equity	16.3B	16.7B	16.9B	4.6B	5.3B	10.1B

When determining whether Exelon offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Exelon's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Exelon Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Exelon Stock:

How To Invest In Exelon

Details

Is Exelon Stock a good investment?

Details

What is Exelon's Net Worth?

Details

Largest Electric Utilities Companies

View

Largest Utilities - Regulated Electric Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Exelon. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.

For information on how to trade Exelon Stock refer to our How to Trade Exelon Stock guide.

You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for Exelon Stock analysis

When running Exelon's price analysis, check to measure Exelon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Exelon is operating at the current time. Most of Exelon's value examination focuses on studying past and present price action to predict the probability of Exelon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Exelon's price. Additionally, you may evaluate how the addition of Exelon to your portfolios can decrease your overall portfolio volatility.

	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Money Managers Screen money managers from public funds and ETFs managed around the world
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges

Is Exelon's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exelon. If investors know Exelon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Exelon listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.02)

Dividend Share

1.46

Earnings Share

2.33

Revenue Per Share

22.268

Quarterly Revenue Growth

0.086

The market value of Exelon is measured differently than its book value, which is the value of Exelon that is recorded on the company's balance sheet. Investors also form their own opinion of Exelon's value that differs from its market value or its book value, called intrinsic value, which is Exelon's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Exelon's market value can be influenced by many factors that don't directly affect Exelon's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Exelon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Exelon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Exelon's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Exelon Non Current Liabilities Total vs Net Receivables Analysis

Non Current Liabilities Total vs Net Receivables

Non Current Liabilities Total vs Net Receivables Correlation Analysis

Correlation Coefficient

Non Current Liabilities Total

Net Receivables

Exelon fundamental ratios Correlations

Exelon Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Exelon fundamental ratios Accounts

Complementary Tools for Exelon Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Non Current Liabilities Total	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Non Current Liabilities Total	+ 1.0	Non Current Assets Total
Total Liab	+ 1.0	Non Current Assets Total

Inventory	- 0.52	Non Currrent Assets Other
Other Stockholder Equity	- 0.51	Cash And Short Term Investments
Other Stockholder Equity	- 0.51	Cash
Net Receivables	- 0.36	Non Currrent Assets Other
Cash And Short Term Investments	- 0.3	Net Debt
Cash	- 0.3	Net Debt